Upregulation of PITX2 Promotes Letrozole Resistance Via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells
Ying-ying Xu, Hai-ru Yu, Jia-yi Sun, Zhao Zhao, Shuang Li, Xin-feng Zhang, Zhi-xuan Liao, Ming-ke Cui, Juan Li, Chan Li, Qiang Zhang
Cancer Res Treat. 2019;51(2):576-592.   Published online 2018 Jul 18     DOI: https://doi.org/10.4143/crt.2018.100
Citations to this article as recorded by Crossref logo
Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis
Chenlu Wu, Jiafei Ying, Mei Dai, Jing Peng, Danhua Zhang
Journal of Cancer Research and Clinical Oncology.2022; 148(12): 3385.     CrossRef
MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells
Zining Liu, Weili Zhang, Biao Zhang, Shaomu Chen, Chunhua Ling
Genetic Testing and Molecular Biomarkers.2022; 26(7-8): 351.     CrossRef
Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression
Olivia K. Provance, Eric S. Geanes, Asona J. Lui, Anuradha Roy, Sean M. Holloran, Sumedha Gunewardena, Christy R. Hagan, Scott Weir, Joan Lewis-Wambi
Cancer Letters.2021; 514: 12.     CrossRef
The significance of homeodomain transcription factor 2 in colon cancer cells
Yang He, Peng Gong, Sitong Wang, Qing Xu, Jianhua Chen
BioMedical Engineering OnLine.2021;[Epub]     CrossRef
Forkhead-box A3 (FOXA3) Represses Cancer Stemness and Partially Potentiates Chemosensitivity by Targeting Metastasis-Associated in Colon Cancer 1 (MACC1) Signaling Pathway in Colorectal Cancer Cells
Na Li, Yun Li, Hongbo Gao, Jing Li, Xiaoping Ma, Xiaomei Liu, Ping Gong, Xiaobin Cui, Yong Li
Current Cancer Drug Targets.2021; 21(3): 254.     CrossRef
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients
Rudolf Napieralski, Gabriele Schricker, Gert Auer, Michaela Aubele, Jonathan Perkins, Viktor Magdolen, Kurt Ulm, Moritz Hamann, Axel Walch, Wilko Weichert, Marion Kiechle, Olaf G. Wilhelm
Breast Care.2021; 16(5): 523.     CrossRef
Downregulation of PITX2 inhibits the proliferation and migration of liver cancer cells and induces cell apoptosis
Kebinuer Tuerxun, Shufang Zhang, Yuexin Zhang
Open Life Sciences.2021; 16(1): 1322.     CrossRef
Deciphering the Roles of IFITM1 in Tumors
Renba Liang, Xinxiao Li, Xiaodong Zhu
Molecular Diagnosis & Therapy.2020; 24(4): 433.     CrossRef
Interferon-induced transmembrane protein 1 (IFITM1) is essential for progression of laryngeal squamous cell carcinoma in an Osteopontin/NF-κB-dependent manner
Yong Yin, Keke Yang, Juanjuan Li, Peng Da, Zhenxin Zhang, Xiaoxia Qiu
Cancer Biomarkers.2020; 29(4): 521.     CrossRef
DNA methylation events in transcription factors and gene expression changes in colon cancer
Anna Díez-Villanueva, Rebeca Sanz-Pamplona, Robert Carreras-Torres, Ferran Moratalla-Navarro, M Henar Alonso, Laia Paré-Brunet, Susanna Aussó, Elisabet Guinó, Xavier Solé, David Cordero, Ramón Salazar, Maria Berdasco, Miguel A Peinado, Victor Moreno
Epigenomics.2020; 12(18): 1593.     CrossRef
PITX2 enhances progression of lung adenocarcinoma by transcriptionally regulating WNT3A and activating Wnt/β-catenin signaling pathway
Jing Luo, Yu Yao, Saiguang Ji, Qi Sun, Yang Xu, Kaichao Liu, Qiang Diao, Yong Qiang, Yi Shen
Cancer Cell International.2019;[Epub]     CrossRef